Biogen Up Over 31%, On Pace for Record Percent Increase -- Data Talk

Biogen Inc. (BIIB) is currently at $294.00, up $70.49 or 31.54%

-- Would be highest close since March 20, 2019, when it closed at $320.59

-- Would be largest percent increase on record (Based on available data back to Sept. 17, 1991)

-- Earlier Tuesday, Biogen said it will seek regulatory approval early next year for an Alzheimer's disease drug some seven months after pulling the plug on late-stage studies of the drug

-- The company posted third-quarter net income of $1.55 billion, or $8.39 a share, compared with $1.44 billion, or $7.15 a share, in the comparable quarter last year. Analysts polled by FactSet were expecting $7.82 a share

-- Currently up two consecutive days; up 33.6% over this period

-- Best two day stretch since the two days ending June 2, 2000, when it rose 35.46%

-- Up 26.28% month-to-date

-- Down 2.3% year-to-date

-- Down 7.01% from 52 weeks ago (Oct. 23, 2018), when it closed at $316.15

-- Up 42.28% at today's intraday high; largest intraday percent increase on record (Based on available data back to Sept. 17, 1991)

-- Best performer in the S&P 500 today

-- Fifth most active stock in the S&P 500 today

-- Best performer in the Nasdaq 100 today

-- Second most active stock in the Nasdaq 100 today

All data as of 10:42:04 AM

Source: Dow Jones Market Data, FactSet